Canadian innovation revolutionizes menstrual health worldwide with the Bfree Cup – The world’s first boil-free, antibacterial menstrual cup

The Bfree Cup is a game-changing antibacterial menstrual cup that promotes gender equity and combats period poverty.
University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis

Discover how Afynia Laboratories secured a $5 million seed round to commercialize its microRNA panel test for endometriosis.
Three McMaster professors awarded fellowships to grow their life science startups

Discover the winners of the 2025 McMaster Professor Entrepreneur Fellowship and their commitment to turning ideas into real impact.
Vessl Prosthetics secures oversubscribed pre-seed funding to drive innovation in prosthetic solutions

This funding will enable Vessl to accelerate the development of its cutting-edge prosthetic devices, advancing the company’s mission to empower amputees to live fuller, more independent lives.
Advancing women’s health: Femtech Canada Forum unites key leaders in Montréal

Read more about the 2024 Femtech Canada Forum, where industry leaders and pioneers gathered to discuss opportunities and gaps in the sector.
Afynia Labs announces $2 million CAD to bring endometriosis test to market

Hamilton-based femtech company Afynia Labs, led by former McMaster scientists, is on a mission to improve how endometriosis is diagnosed.
Women’s health care research is largely based on males. That’s starting to change — slowly

Dr. Jocelyn Wessels of Afynia Labs weighs in on the state of women’s healthcare and what male investors can do to help close the gap.
How femtech companies are tackling gender health gaps while empowering women

Growing a femtech company brings more challenges than successes, but these founders are focused on closing the women’s healthcare gap.
OBIO® Celebrates the Advancement of Women in Health Science with WiHI Seed Program and Leadership Awards

11 women-led companies have been selected for the OBIO® WiHI Seed Program.